Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 9, 2004
Aastrom Biosciences, Inc.
(Exact name of registrant as specified in charter)
| Michigan | 0-22025 | 94-3096597 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
||
| 24 Frank Lloyd Wright Drive, P.O. Box 376, Ann Arbor, Michigan | 48106 | |
| (Address of principal executive offices) | (Zip Code) | |
Registrant’s telephone number, including area code (734) 930-5555
Not Applicable
| Item 5. Other Events. | ||||||||
| SIGNATURES | ||||||||
Table of Contents
Item 5. Other Events.
On July 9, 2004, Mr. Robert J. Bard advised Aastrom Biosciences that effective July 23, 2004, he was resigning his position as Vice President Regulatory Affairs and Quality Systems to accept a position with another company. While the Company seeks a replacement for Mr. Bard, his duties and responsibilities will be performed by various members of Aastrom’s management and staff.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Aastrom Biosciences, Inc. |
||||
| Date: July 13, 2004 | By: | /s/ Alan M. Wright | ||
| Senior Vice President | ||||
| Administrative and Financial Operations, CFO | ||||